Clinical trial BSMO 2014 01
A prospective, Belgian multi-center, single-arm, phase II study of neoadjuvant weekly paclitaxel and carboplatin followed by dose dense epirubicin and cyclophosphamide in stage II and III triple negative breast cancer
| Cancers | |
|---|---|
| Organ | Breast |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Oui |
| Sponsor | UZ-Brussel |
| EudraCT Identifier | 2014-003723-21 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04224922 |
| Inclusion criteria | TNBC |
| Last update |